PFN1 and head and neck squamous cell carcinoma: When analyzing the third of the functional partners of ABP-PFN1, it was found that its content in the serum was almost two times higher in HNSCC patients with lymph node metastasis (T2–4N1–2M0) than that in patients without metastases (T1–3N0M0).